Literature DB >> 31431943

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis.

Ourania S Kotsiou1, Zoe Daniil2, Konstantinos I Gourgoulianis2.   

Abstract

Entities:  

Year:  2017        PMID: 31431943      PMCID: PMC6649933          DOI: 10.1093/rap/rkx003

Source DB:  PubMed          Journal:  Rheumatol Adv Pract        ISSN: 2514-1775


× No keyword cloud information.
A non-smoking 60-year-old Caucasian woman presented with acute onset of dyspnoea and chest tightness. She was haemodynamically stable but tachypneic. Arterial blood gas analysis in room air showed pH values of 7.29, oxygen partial pressure of 50 mmHg and carbon dioxide partial pressure of 65 mmHg. Clinical examination revealed subcutaneous emphysema around the neck. She also showed the shawl sign, the neckline V sign and Gottron’s papules located on the metacarpophalangeal and proximal interphalangeal joints. She complained of arthralgias over the previous 6 months without muscle weakness. Late inspiratory crackles could be heard over the lungs. She had normal serum creatine kinase, liver enzymes and lactate dehydrogenase values. Chest CT showed pneumomediastinum, pneumopericardium, bilateral interstitial thickening and ground glass opacities (Fig. 1). The skin biopsy confirmed the diagnosis of DM. Anti-MDA5 antibodies were identified in line-blot assay. The electromyography was normal. The patient was diagnosed with anti-MDA5-positive clinically amyopathic DM. Spontaneous pneumomediastinum is rarely a presenting symptom of DM [1]. It tends to occur with rapid progressive intestinal lung disease, anti-MDA5 antibody and clinically amyopathic DM, constituting a devastating complication [2]. The patient died shortly thereafter.
. 1

Chest CT shows pneumomediastinum, pneumopericardium (arrowheads), bilateral interstitial thickening and ground glass opacities (arrows)

Chest CT shows pneumomediastinum, pneumopericardium (arrowheads), bilateral interstitial thickening and ground glass opacities (arrows)
  2 in total

1.  Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum.

Authors:  Xiaolei Ma; Zhiyong Chen; Wei Hu; Ziwei Guo; Yan Wang; Masataka Kuwana; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2015-07-07       Impact factor: 2.980

2.  Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.

Authors:  Shuang Ye; Xiao-xiang Chen; Xiao-ye Lu; Mei-fang Wu; Yun Deng; Wen-qun Huang; Qiang Guo; Cheng-de Yang; Yue-ying Gu; Chun-de Bao; Shun-le Chen
Journal:  Clin Rheumatol       Date:  2007-02-17       Impact factor: 2.980

  2 in total
  2 in total

Review 1.  Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.

Authors:  Daniel Gonzalez; Latika Gupta; Vijaya Murthy; Emilio B Gonzalez; Katrina A Williamson; Ashima Makol; Chou Luan Tan; Farah Nadiah Sulaiman; Nor Shuhaila Shahril; Liza Mohd Isa; Eduardo Martín-Nares; Rohit Aggarwal
Journal:  Rheumatol Int       Date:  2022-06-04       Impact factor: 3.580

2.  Interstitial lung disease-related pneumomediastinum in COVID-19 patients.

Authors:  Kim Blanc; Nicolas Bonnet; Elise Ouedraogo; Michel Arnaout; Maxime Patout; Yacine Tandjaoui-Lambiotte
Journal:  ERJ Open Res       Date:  2021-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.